Want to see AU:SHG full AI Analyst Report?
Top Page
Singular Health Group Ltd
(Sydney:SHG)
Select Model
Select Model
Rating:44Neutral
Price Target:
AU$0.16
▼(-40.38% Downside)
Action:Reiterated
Date:10/14/26
The score is held down primarily by sustained losses, negative margins (including negative gross profit in 2026), and ongoing cash burn, despite improved revenue momentum and a less leveraged balance sheet. Technicals are mixed with a weak longer-term trend, and valuation remains constrained by negative earnings and no indicated dividend support.
Positive Factors
Revenue Growth
The latest period shows meaningful revenue traction, indicating that Singular Health Group is generating greater commercial activity from its offerings. If this growth persists, it can improve operating leverage, broaden customer adoption, and provide a foundation for eventual profitability.
Negative Factors
Persistent Unprofitability
Negative gross profit and deeply negative operating results show that the current revenue base is not yet covering the economics of the business. Without sustained improvement in pricing, delivery efficiency, or scale, continued losses could restrict reinvestment and weaken financial resilience.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The latest period shows meaningful revenue traction, indicating that Singular Health Group is generating greater commercial activity from its offerings. If this growth persists, it can improve operating leverage, broaden customer adoption, and provide a foundation for eventual profitability.
Read all positive factors
Singular Health Group Ltd (SHG) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$58.70M
Dividend YieldN/A
Average Volume (3M)313.06K
Price to Earnings (P/E)―
Beta (1Y)0.86
Revenue Growth603.32%
EPS Growth10.57%
CountryAU
Employees8
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.02
Shares Outstanding326,091,300
10 Day Avg. Volume322,245
30 Day Avg. Volume313,062
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)6.53
Price to Sales (P/S)48.14
P/FCF Ratio-12.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.31Price Target Upside19.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)AU$4.90M
Singular Health Group Ltd Business Overview & Revenue Model
Company Description
Singular Health Group Ltd operates as a medical technology enterprise dedicated to developing and commercializing a volumetric rendering platform (VRP). This advanced platform facilitates the three-dimensional and virtual reality presentation of a...
Singular Health Group Ltd Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
46
Neutral
Cash Flow
22
Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.43M | 557.61K | 934.07K | 28.12K | 54.03K |
| Gross Profit | -4.02M | -86.22K | 516.36K | -3.58M | -2.11M |
| EBITDA | -6.69M | -6.27M | -2.58M | -4.52M | -5.65M |
| Net Income | -6.34M | -6.38M | -4.92M | -5.39M | -5.99M |
Balance Sheet | |||||
| Total Assets | 11.24M | 14.21M | 2.35M | 3.00M | 2.14M |
| Cash, Cash Equivalents and Short-Term Investments | 10.06M | 13.68M | 1.45M | 691.51K | 1.14M |
| Total Debt | 109.96K | 0.00 | 218.45K | 2.51M | 85.66K |
| Total Liabilities | 699.20K | 1.11M | 909.59K | 2.94M | 391.50K |
| Stockholders Equity | 10.54M | 13.10M | 1.44M | 61.89K | 1.75M |
Cash Flow | |||||
| Free Cash Flow | -5.45M | -2.37M | -2.51M | -2.49M | -2.92M |
| Operating Cash Flow | -5.30M | -2.34M | -2.44M | -2.46M | -2.91M |
| Investing Cash Flow | 5.37M | 88.14K | -3.56K | -635.21K | -17.12K |
| Financing Cash Flow | 1.67M | 14.48M | 3.21M | 2.65M | -69.25K |
Singular Health Group Ltd Technical Analysis
Positive
0.26
Price Trends
0.18
Positive
0.19
Negative
0.21
Negative
Market Momentum
>-0.01
Negative
56.11
Neutral
78.57
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SHG, the sentiment is Positive. The current price of 0.26 is above the 20-day moving average (MA) of 0.17, above the 50-day MA of 0.18, and above the 200-day MA of 0.21, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 56.11 is Neutral, neither overbought nor oversold. The STOCH value of 78.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:SHG.
Singular Health Group Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | AU$35.31M | 23.13 | 13.72% | ― | 42.25% | ― | |
65 Neutral | AU$155.23M | 67.65 | 2.53% | ― | 26.61% | 41.67% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | AU$58.75M | -6.71 | -24.29% | ― | -17.35% | -47.29% | |
45 Neutral | AU$20.97M | -1.13 | -58.13% | ― | 2.08% | -195.31% | |
44 Neutral | AU$58.70M | -9.11 | -57.06% | ― | 603.32% | 10.57% | |
44 Neutral | AU$446.72M | -15.69 | -30.04% | ― | <0.01% | 2.08% |
* Healthcare Sector Average
AU:SHG
Singular Health Group Ltd
0.18
-0.10
-36.84%
AU:M7T
Mach7 Technologies
0.25
-0.05
-16.67%
AU:RHT
Resonance Health Ltd
0.07
0.02
51.02%
AU:BMT
Beamtree Holdings Ltd
0.07
-0.15
-67.73%
AU:AYA
Artrya Limited
2.73
-0.68
-19.94%
AU:ALC
Alcidion Group Limited
0.12
0.03
27.78%
Singular Health Group Ltd Corporate Events
Singular Health sets date and access details for 2026 AGM
Oct 6, 2026
Singular Health Group has announced that its 2026 Annual General Meeting will be held in person at Automic Group’s offices in Perth on 26 November 2026 at 11:00am AWST, with the Notice of Meeting and Explanatory Memorandum available online v...
Singular Health to Brief Investors on U.S. Imaging Repository Progress
Oct 1, 2026
Singular Health Group Ltd will host an online investor webinar on 8 October 2026, led by managing director Denning Chong and chief operating officer Dr Martina Mariano, to brief shareholders and investors on the company’s operations. Managem...
Singular Health Sets November Date for 2026 AGM and Opens Director Nominations
Sep 30, 2026
Singular Health Group Ltd has issued advance notice that its 2026 Annual General Meeting is expected to be held around Thursday 26 November 2026, with full meeting details and resolutions to be circulated in a formal Notice of Meeting and Explanat...
Singular Health Secures Florida Medicaid Imaging Repository Deal With FIU
Sep 28, 2026
Singular Health Group has signed an amended memorandum of understanding with Florida International University to design, deliver and operate a secure medical imaging data repository for Florida’s Medicaid program using its 3DICOM platform. T...
Singular Health Lodges ASX Corporate Governance Statement and Appendix 4G
Aug 30, 2026
Singular Health Group Ltd, an ASX-listed entity, has detailed its governance framework for the year ended 30 June 2026, including a board charter, appointment processes for directors and senior executives, and the company secretary’s direct ...
Singular Health boosts revenue and expands globally despite ongoing losses
Aug 30, 2026
Singular Health Group Limited reported a sharp increase in revenues from ordinary activities to $1.43 million for the year ended 30 June 2026, up 507% from the prior year, while its loss after tax narrowed slightly to $6.34 million. Net tangible a...
Singular Health Group Seeks ASX Quotation for 1.8 Million New Shares
Aug 17, 2026
Singular Health Group Ltd has applied for quotation on the ASX of 1,818,182 ordinary fully paid shares, with an issue date of 17 August 2026. The new share quotation expands the company’s listed equity base, potentially enhancing liquidity f...
Singular Health builds U.S. imaging footprint with PNS expansion, Florida pilots and Miami-Dade rollout
Jul 31, 2026
Singular Health Group reported a quarter of commercial and operational momentum, highlighting deeper engagement with U.S. healthcare payers and education providers as it builds out scalable imaging infrastructure solutions. The company ended the J...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.